Is bedaquiline included in medical insurance and can it be reimbursed?

Bedaquiline is a new anti-tuberculosis drug mainly used to treat patients with multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). As the demand for the prevention and treatment of drug-resistant tuberculosis continues to increase, bedaquiline as an innovative drug has gained widespread attention around the world. In recent years, bedaquiline has been officially approved for marketing in China and has become an important part of domestic tuberculosis treatment.

It is worth noting that bedaquiline has been included in China’s national medical insurance directory, and patients can enjoy the medical insurance reimbursement policy if they meet relevant treatment standards and regulations. The inclusion of medical insurance not only greatly reduces patients' medication burden, but also promotes the popularization and standardized use of drugs in primary medical institutions. The specific reimbursement ratio and payment standards may vary due to differences in regional medical insurance policies. Patients are advised to consult the local hospital pharmacy or medical insurance department for detailed cost reimbursement information before purchasing drugs.

In actual clinical applications, bedaquiline is accepted by more and more tuberculosis patients due to its significant efficacy and good safety. The price of the original version is relatively high, with the cost of each course of treatment being about more than 10,000 yuan, while the price of the imitation version produced in countries such as India is more affordable, about 2,000 to 3,000 yuan. Although generic drugs are low in price, patients should give priority to purchasing drugs through formal channels with guaranteed quality to ensure drug safety and therapeutic effect.

Overall, medical insurance coverage of bedaquiline has greatly improved treatment accessibility for drug-resistant tuberculosis patients and reduced the economic burden. In the future, with the improvement of medical insurance policies in more regions and the stability of the drug supply chain, the application of bedaquiline in the country is expected to be further promoted, helping my country's tuberculosis prevention and control work to achieve greater progress. Patients should follow the doctor's guidance during use and use medications rationally to ensure efficacy and safety.

Reference materials:https://www.drugs.com/